In our case, the here-demonstrated prooxidant effect of the phenolic extracts of pomaces will be firstly tested for their antiproliferative and proapoptotic activity on melanoma cell lines established from patients at various stages of the disease and characterized by different molecular features (BRAF or NRAS mutation, high or low tumor mutation burden, etc.), as already being pursued [85]. Here, NRAS is linked to melanoma.